|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
51988677
Online Users :
864
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 301041-301050 of 2348419 (234842 Page(s) Totally)
<< < 30100 30101 30102 30103 30104 30105 30106 30107 30108 30109 > >>
View [10|25|50] records per page
| 中國醫藥大學 |
2007.09 |
Cytogenetic variability in the proportion of abnormal cells between the various tissues in prenatally detected mosaic tetrasomy 12p
|
陳持平(Chen CP)*; 蔡輔仁(Fuu-Jen Tsai); (Chern SR); (Lee CC); (Town DD); (Wang W) |
| 臺大學術典藏 |
2020-09-29T16:47:19Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, YW; Tsai, CH; Lin, CC; Tien, FM; Chen, YW; HSIN-YI LIN; Yao, M; Lin, YC; Lin, CT; Cheng, CL; Tang, JL; Chou, WC; Hou, HA; Tien, HF |
| 臺大學術典藏 |
2020-10-28T08:35:05Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; CHENG-HONG TSAI; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F.; Yao M.; Lin H.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Hou H.-A.; Chou W.-C.; Tang J.-L.; Cheng C.-L.; Lin C.-T.; Lin Y.-C.; MING YAO; Lin H.-Y.; Chen Y.-W.; Tien F.-M.; Lin C.-C.; Tsai C.-H.; Wang Y.-W.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:30Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; TIEN FENG-MING; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.;Tsai C.-H.;Lin C.-C.;Tien F.-M.;Chen Y.-W.;Lin H.-Y.;Yao M.;Lin Y.-C.;Lin C.-T.;Cheng C.-L.;Tang J.-L.;Wen-Chien Chou;Hou H.-A.;Tien H.-F.; Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; WEN-CHIEN CHOU; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; FENG-MING TIEN; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
Showing items 301041-301050 of 2348419 (234842 Page(s) Totally)
<< < 30100 30101 30102 30103 30104 30105 30106 30107 30108 30109 > >>
View [10|25|50] records per page
|
